Long-acting GHRH analogue commonly referenced in growth hormone research.
| Purity | ≥99.3% |
| Category | Growth Hormone |
| Available Sizes | 5mg, 10mg |
| Batch Number | #NZP-CJC-0209 |
| Last Tested | 08 Aug 2026 |
| Storage | Store lyophilised vial at -20°C, protect from light |
Batch #NZP-CJC-0209 · Independently tested 08 Aug 2026
CJC-1295 is a long-acting analogue of growth-hormone releasing hormone (GHRH), commonly referenced in growth hormone axis research. Its extended activity profile makes it a frequently cited compound in comparative research models. Supplied strictly for laboratory research use, with every batch independently verified for purity.
Every peptide we stock is manufactured under strict quality control and independently verified by a third-party New Zealand laboratory before release. Each vial is single-use, tamper-sealed, and shipped with a batch-matched Certificate of Analysis confirming identity and purity.
This product is sold strictly for laboratory and in-vitro research purposes. It is not a drug, food, cosmetic, or dietary supplement, and is not intended for human or animal consumption, diagnostic, or therapeutic use. By purchasing this product you confirm that you are a qualified researcher and agree to our full research use disclaimer.
You May Also Need
Other research compounds frequently ordered alongside CJC-1295.
Growth-hormone releasing factor analogue used in metabolic research studies.
Selective growth hormone secretagogue studied for its targeted receptor activity.
Pentadecapeptide widely studied in tissue repair and recovery research models.
Chat to our team directly on WhatsApp — we usually reply within minutes.